Small,
Journal Year:
2024,
Volume and Issue:
20(25)
Published: Jan. 14, 2024
Abstract
Ferroptosis
is
a
new
form
of
regulated
cell
death
featuring
iron‐dependent
lipid
peroxides
accumulation
to
kill
tumor
cells.
A
growing
body
evidence
has
shown
the
potential
ferroptosis‐based
cancer
therapy
in
eradicating
refractory
malignancies
that
are
resistant
apoptosis‐based
conventional
therapies.
In
recent
years,
studies
have
reported
number
ferroptosis
inducers
can
increase
vulnerability
cells
by
regulating
ferroptosis‐related
signaling
pathways.
Encouraged
rapid
development
ferroptosis‐driven
therapies,
interdisciplinary
fields
combine
ferroptosis,
pharmaceutical
chemistry,
and
nanotechnology
focused.
First,
prerequisites
metabolic
pathways
for
briefly
introduced.
Then,
detail
emerging
designed
boost
ferroptosis‐induced
therapy,
including
metal
complexes,
metal‐based
nanoparticles,
metal‐free
nanoparticles
summarized.
Subsequently,
application
synergistic
strategies
with
apoptosis
other
emphasis
on
use
both
cuproptosis
induce
redox
dysregulation
intracellular
bimetallic
copper/iron
metabolism
disorders
during
treatment
discussed.
Finally,
challenges
associated
clinical
translation
future
directions
potentiating
therapies
highlighted.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Aug. 25, 2023
Precise
and
efficient
image-guided
immunotherapy
holds
great
promise
for
cancer
treatment.
Here,
we
report
a
self-accelerated
nanoplatform
combining
an
aggregation-induced
emission
luminogen
(AIEgen)
hypoxia-responsive
prodrug
multifunctional
combination
immunotherapy.
The
near-infrared
AIEgen
with
methoxy
substitution
simultaneously
possesses
boosted
fluorescence
photoacoustic
(PA)
brightness
the
strong
light
absorption
ability,
as
well
amplified
type
I
II
photodynamic
therapy
(PDT)
properties
via
enhanced
intersystem
crossing
process.
By
formulating
high-performance
paclitaxel
(PTX)
into
nanoparticles,
further
camouflaging
macrophage
cell
membrane,
tumor-targeting
theranostic
agent
is
built.
integration
of
PA
imaging
helps
to
delineate
tumor
site
sensitively,
providing
accurate
guidance
light-induced
PDT
effect
could
consume
local
oxygen
lead
severer
hypoxia,
accelerating
release
PTX
drug.
As
result,
chemotherapy
induces
immunogenic
death,
which
not
only
elicit
antitumor
immunity
suppress
primary
tumor,
but
also
inhibit
growth
distant
in
4T1
tumor-bearing
female
mice.
strategy
develop
agents
rational
molecular
design
boosting
Advanced Healthcare Materials,
Journal Year:
2023,
Volume and Issue:
12(25)
Published: April 13, 2023
Diabetic
wounds
are
characterized
by
drug-resistant
bacterial
infections,
biofilm
formation,
impaired
angiogenesis
and
perfusion,
oxidative
damage
to
the
microenvironment.
Given
their
complex
nature,
diabetic
remain
a
major
challenge
in
clinical
practice.
Reactive
oxygen
species
(ROS),
which
have
been
shown
trigger
hyperinflammation
excessive
cellular
apoptosis,
play
pivotal
role
pathogenesis
of
wounds.
ROS-scavenging
nanosystems
recently
emerged
as
smart
multifunctional
nanomedicines
with
broad
synergistic
applicability.
The
documented
anti-inflammatory
pro-angiogenic
ability
treatments
predestines
these
promising
options
for
treatment
Yet,
this
context,
therapeutic
applicability
efficacy
be
elucidated.
Herein,
ROS
is
deciphered,
properties
strengths
capacity
summarized.
In
addition,
current
challenges
such
potential
future
directions
discussed
through
clinical-translational
lens.
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
34(31)
Published: June 15, 2022
Immunotherapy
has
received
tremendous
attention
for
tumor
treatment,
but
the
efficacy
is
greatly
hindered
by
insufficient
tumor-infiltration
of
immune
cells
and
immunosuppressive
microenvironment.
The
strategy
that
can
efficiently
activate
cytotoxic
T
lymphocytes
inhibit
negative
regulators
will
amplify
immunotherapy
outcome,
which
however
very
rare.
Herein,
a
new
kind
semiconducting
polymer
(SP)
nanoparticles
developed,
featured
with
surface-mimicking
protein
secondary
structure
(SPSS
NPs)
self-synergistic
cancer
combining
immunogenic
cell
death
(ICD)
checkpoint
blockade
therapy.
SPs
excellent
photodynamic
property
are
synthesized
rational
fluorination,
massively
induce
ICD.
Additionally,
peptide
antagonists
introduced
self-assembled
into
β-sheet
structures
on
NP
surface
via
preparation
process
optimization,
function
as
efficient
lysosome-targeting
chimaeras
(LYTACs)
to
mediate
degradation
programmed
ligand-1
(PD-L1)
in
lysosome.
In
vivo
experiments
demonstrate
SPSS
NPs
not
only
elicit
strong
antitumor
immunity
suppress
both
primary
distant
tumor,
also
evoke
long-term
immunological
memory
against
rechallenge.
This
work
introduces
robust
agents
well-designed
photosensitizer-based
ICD
induction
structures-mediated
LYTAC-like
multivalence
PD-L1
blockade,
rendering
great
promise
synergistic
immunotherapy.
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
34(30)
Published: June 7, 2022
Osteoarthritis
(OA)
is
a
low-grade
inflammatory
and
progressive
joint
disease,
its
progression
closely
associated
with
an
imbalance
in
M1/M2
synovial
macrophages.
Repolarizing
pro-inflammatory
M1
macrophages
into
the
anti-inflammatory
M2
phenotype
emerging
as
strategy
to
alleviate
OA
but
compromised
by
unsatisfactory
efficiency.
In
this
study,
reprogramming
of
mitochondrial
dysfunction
pioneered
camouflaged
meta-Defensome,
which
can
transform
high
efficiency
82.3%.
The
meta-Defensome
recognizes
activated
via
receptor-ligand
interactions
accumulates
mitochondria
through
electrostatic
attractions.
These
meta-Defensomes
are
macrophage-membrane-coated
polymeric
nanoparticles
decorated
dual
ligands
co-loaded
S-methylisothiourea
MnO2
.
Meta-Defensomes
demonstrated
successfully
reprogram
metabolism
scavenging
reactive
oxygen
species
inhibiting
NO
synthase,
thereby
increasing
transcription
factor
A
expression
restoring
aerobic
respiration.
Furthermore,
intravenously
injected
collagenase-induced
osteoarthritis
mice
effectively
suppress
inflammation
early
OA,
evident
from
Research
Society
International
score.
Therefore,
serve
novel
practical
approach
repolarize
promising
therapeutic
agent
for
impeding
tclinic.
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
34(21)
Published: March 31, 2022
Although
photothermal
immunotherapy
(PTI)
is
a
compelling
strategy
for
tumor
therapy,
the
development
of
promising
agents
to
overcome
insufficient
immunogenicity
cells
and
poor
immune
response
encountered
in
PTI
still
challenging.
Herein,
commercial
small-molecule-based
organic
metal
adjuvants
(OMAs)
are
presented,
with
second
near-infrared
photoacoustic
properties
as
well
ability
perturb
redox
homeostasis
potentiate
responsiveness.
OMAs,
assembled
from
charge-transfer
complexes
characterized
by
broad
substrate
scope,
high
accessibility,
flexibly
tuned
optical
properties,
demonstrate
strong
phototherapeutic
adjuvant
abilities
via
depletion
glutathione
cysteine,
subsequently
elicit
systemic
immunity
evoking
immunogenic
cell
death,
promoting
dendritic
maturation,
increasing
T
infiltration.
Furthermore,
programmed
death
protein
1
antibody
can
be
employed
synergize
OMAs
suppress
evasion
ultimately
improve
treatment
outcomes.
This
study
unlocks
new
paradigms
provide
versatile
OMA-based
scaffold
future
practical
applications.
RSC Advances,
Journal Year:
2023,
Volume and Issue:
13(21), P. 14443 - 14460
Published: Jan. 1, 2023
This
review
summarizes
the
common
inorganic
and
organic
photothermal
nanoagents
their
applications
in
tumor
therapy.
Additionally,
challenges
future
prospects
of
nanomaterial-based
therapy
cancer
treatment
are
discussed.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(19), P. 12049 - 12095
Published: May 2, 2024
Cancer,
as
one
of
the
leading
causes
death
worldwide,
drives
advancement
cutting-edge
technologies
for
cancer
treatment.
Transition-metal-based
nanozymes
emerge
promising
therapeutic
nanodrugs
that
provide
a
reference
therapy.
In
this
review,
we
present
recent
breakthrough
First,
comprehensively
outline
preparation
strategies
involved
in
creating
transition-metal-based
nanozymes,
including
hydrothermal
method,
solvothermal
chemical
reduction
biomimetic
mineralization
and
sol–gel
method.
Subsequently,
elucidate
catalytic
mechanisms
(catalase
(CAT)-like
activities),
peroxidase
(POD)-like
oxidase
(OXD)-like
activities)
superoxide
dismutase
(SOD)-like
along
with
their
activity
regulation
such
morphology
control,
size
manipulation,
modulation,
composition
adjustment
surface
modification
under
environmental
stimulation.
Furthermore,
elaborate
on
diverse
applications
anticancer
therapies
encompassing
radiotherapy
(RT),
chemodynamic
therapy
(CDT),
photodynamic
(PDT),
photothermal
(PTT),
sonodynamic
(SDT),
immunotherapy,
synergistic
Finally,
challenges
faced
by
are
discussed
alongside
future
research
directions.
The
purpose
review
is
to
offer
scientific
guidance
will
enhance
clinical
based
transition
metals.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
36(2)
Published: Sept. 21, 2023
Abstract
Taking
the
significance
of
special
microenvironment
for
tumor
cell
survival
into
account,
disrupting
redox
homeostasis
is
highly
prospective
improving
therapeutic
efficacy.
Herein,
a
multifunctional
2D
vanadium‐based
MXene
nanoplatform,
V
4
C
3
/atovaquone@bovine
albumin
(V
/ATO@BSA,
abbreviated
as
VAB)
has
been
elaborately
constructed
ATO‐enhanced
nanozyme
catalytic/photothermal
therapy.
The
within
cells
eventually
disrupted,
showing
remarkable
anti‐tumor
effect.
VAB
nanoplatform
with
mixed
vanadium
valence
states
can
induce
cascade
catalyzed
reactions
in
microenvironment,
generating
plenty
reactive
oxygen
species
(ROS)
effective
glutathione
consumption
to
amplify
oxidative
stress.
Meanwhile,
stable
and
strong
photothermal
effect
under
near‐infrared
irradiation
not
only
causes
necrosis
cells,
but
also
improves
its
peroxidase‐like
activity.
In
addition,
release
ATO
effectively
alleviate
endogenous
limit
triphosadenine
formation
inhibit
mitochondrial
respiration.
As
result,
expression
heat
shock
proteins
suppressed
overcome
thermoresistance
production
ROS
be
further
promoted
due
injury.
Moreover,
presents
high
photoacoustic
imaging
performances.
brief,
provide
therapy
broadening
biomedical
applications
MXene.